A phase II trial of cemiplimab alone or in combination with standard of care chemotherapy in locally advanced or metastatic penile carcinoma (EPIC Trial)
(2022)
Journal Article
Renninson, E., Challapalli, A., Foulstone, E., Bravo, A., Soundy, A., Callaway, M., …Bahl, A. (2022). A phase II trial of cemiplimab alone or in combination with standard of care chemotherapy in locally advanced or metastatic penile carcinoma (EPIC Trial). Journal of Clinical Oncology, 40(16_suppl), TPS5094-TPS5094. https://doi.org/10.1200/jco.2022.40.16_suppl.tps5094
TPS5094 Background: Penile cancer (PC) is rare but its incidence is increasing, with an increase of 21% over the last decade. The rarity of this cancer means a paucity of large prospective clinical trial data to guide the management of locally advanc... Read More about A phase II trial of cemiplimab alone or in combination with standard of care chemotherapy in locally advanced or metastatic penile carcinoma (EPIC Trial).